These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 27207465)
1. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer's disease. Shu L; Sun W; Li L; Xu Z; Lin L; Xie P; Shen H; Huang L; Xu Q; Jin P; Li X BMC Genomics; 2016 May; 17():381. PubMed ID: 27207465 [TBL] [Abstract][Full Text] [Related]
2. Reduction of Tet2 exacerbates early stage Alzheimer's pathology and cognitive impairments in 2×Tg-AD mice. Li L; Qiu Y; Miao M; Liu Z; Li W; Zhu Y; Wang Q Hum Mol Genet; 2020 Jul; 29(11):1833-1852. PubMed ID: 31943063 [TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity. Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332 [TBL] [Abstract][Full Text] [Related]
4. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984 [TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease. Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677 [TBL] [Abstract][Full Text] [Related]
6. Role of TET1-mediated epigenetic modulation in Alzheimer's disease. Armstrong MJ; Jin Y; Vattathil SM; Huang Y; Schroeder JP; Bennet DA; Qin ZS; Wingo TS; Jin P Neurobiol Dis; 2023 Sep; 185():106257. PubMed ID: 37562656 [TBL] [Abstract][Full Text] [Related]
7. Integrated analyses of 5 mC, 5hmC methylation and gene expression reveal pathology-associated AKT3 gene and potential biomarkers for Alzheimer's disease. Shen Y; Zhu W; Li S; Zhang Z; Zhang J; Li M; Zheng W; Wang D; Zhong Y; Li M; Zheng H; Du J J Psychiatr Res; 2024 Oct; 178():367-377. PubMed ID: 39197298 [TBL] [Abstract][Full Text] [Related]
8. Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease. Zhang Y; Zhang Z; Li L; Xu K; Ma Z; Chow HM; Herrup K; Li J FASEB J; 2020 Dec; 34(12):16364-16382. PubMed ID: 33058355 [TBL] [Abstract][Full Text] [Related]
9. Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease. Qin L; Xu Q; Li Z; Chen L; Li Y; Yang N; Liu Z; Guo J; Shen L; Allen EG; Chen C; Ma C; Wu H; Zhu X; Jin P; Tang B Hum Mol Genet; 2020 Jan; 29(1):149-158. PubMed ID: 31814020 [TBL] [Abstract][Full Text] [Related]
10. A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease. Zhao J; Zhu Y; Yang J; Li L; Wu H; De Jager PL; Jin P; Bennett DA Alzheimers Dement; 2017 Jun; 13(6):674-688. PubMed ID: 28089213 [TBL] [Abstract][Full Text] [Related]
11. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease. Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954 [TBL] [Abstract][Full Text] [Related]
12. Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease. Lardenoije R; van den Hove DLA; Havermans M; van Casteren A; Le KX; Palmour R; Lemere CA; Rutten BPF Mol Cell Neurosci; 2018 Jan; 86():1-15. PubMed ID: 29113959 [TBL] [Abstract][Full Text] [Related]
13. Active Amyloid-β Vaccination Results in Epigenetic Changes in the Hippocampus of an Alzheimer's Disease-Like Mouse Model. Lardenoije R; van den Hove DLA; Jung SE; Havermans M; Blackburn P; Liu B; Rutten BPF; Lemere CA Curr Alzheimer Res; 2019; 16(9):861-870. PubMed ID: 31453788 [TBL] [Abstract][Full Text] [Related]
14. Age-related epigenome-wide DNA methylation and hydroxymethylation in longitudinal mouse blood. Kochmanski J; Marchlewicz EH; Cavalcante RG; Sartor MA; Dolinoy DC Epigenetics; 2018; 13(7):779-792. PubMed ID: 30079798 [TBL] [Abstract][Full Text] [Related]
15. Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects. Ellison EM; Bradley-Whitman MA; Lovell MA J Mol Neurosci; 2017 Oct; 63(2):185-197. PubMed ID: 28866733 [TBL] [Abstract][Full Text] [Related]
16. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease. Cadena-del-Castillo C; Valdes-Quezada C; Carmona-Aldana F; Arias C; Bermúdez-Rattoni F; Recillas-Targa F J Alzheimers Dis; 2014; 41(3):845-54. PubMed ID: 24685633 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease. He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129 [TBL] [Abstract][Full Text] [Related]
18. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology. Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875 [TBL] [Abstract][Full Text] [Related]
19. PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. Fuso A; Cavallaro RA; Nicolia V; Scarpa S Curr Alzheimer Res; 2012 Jun; 9(5):527-35. PubMed ID: 22272624 [TBL] [Abstract][Full Text] [Related]
20. Integrated Genome-Wide Analysis of DNA Methylation and Gene Expression in the Hippocampi of 5xFAD Alzheimer's Disease Mouse Model. Lee S; Lee HJ; Chun JM; Jung B; Kim J; Moon C; Kim C; Kim JS J Integr Neurosci; 2024 Jul; 23(7):138. PubMed ID: 39082299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]